• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫苗接种中心分布的空间分析:以沙特阿拉伯吉达市为例

Spatial Analysis of COVID-19 Vaccine Centers Distribution: A Case Study of the City of Jeddah, Saudi Arabia.

作者信息

Faisal Kamil, Alshammari Sultanah, Alotaibi Reem, Alhothali Areej, Bamasag Omaimah, Alghanmi Nusaybah, Bin Yamin Manal

机构信息

Geomatics Department, Faculty of Architecture and Planning, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Department of Computer Science, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

出版信息

Int J Environ Res Public Health. 2022 Mar 16;19(6):3526. doi: 10.3390/ijerph19063526.

DOI:10.3390/ijerph19063526
PMID:35329216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948971/
Abstract

The COVID-19 pandemic is one of the most devastating public health emergencies in history. In late 2020 and after almost a year from the initial outbreak of the novel coronavirus (SARS-CoV-2), several vaccines were approved and administered in most countries. Saudi Arabia has established COVID-19 vaccination centers in all regions. Various facilities were selected to set up these vaccination centers, including conference and exhibition centers, old airport terminals, pre-existing medical facilities, and primary healthcare centers. Deciding the number and locations of these facilities is a fundamental objective for successful epidemic responses to ensure the delivery of vaccines and other health services to the entire population. This study analyzed the spatial distribution of COVID-19 vaccination centers in Jeddah, a major city in Saudi Arabia, by using GIS tools and methods to provide insight on the effectiveness of the selection and distribution of the COVID-19 vaccination centers in terms of accessibility and coverage. Based on a spatial analysis of vaccine centers' coverage in 2020 and 2021 in Jeddah presented in this study, coverage deficiency would have been addressed earlier if the applied GIS analysis methods had been used by authorities while gradually increasing the number of vaccination centers. This study recommends that the Ministry of Health in Saudi Arabia evaluated the assigned vaccination centers to include the less-populated regions and to ensure equity and fairness in vaccine distribution. Adding more vaccine centers or reallocating some existing centers in the denser districts to increase the coverage in the uncovered sparse regions in Jeddah is also recommended. The methods applied in this study could be part of a strategic vaccination administration program for future public health emergencies and other vaccination campaigns.

摘要

新冠疫情是历史上最具毁灭性的突发公共卫生事件之一。2020年末,在新型冠状病毒(SARS-CoV-2)首次爆发近一年后,多数国家批准并接种了几种疫苗。沙特阿拉伯在所有地区都设立了新冠疫苗接种中心。设立这些接种中心时选用了各种设施,包括会议展览中心、旧机场航站楼、既有医疗设施和基层医疗中心。确定这些设施的数量和地点是成功应对疫情的一项基本目标,以确保向全体民众提供疫苗及其他卫生服务。本研究利用地理信息系统(GIS)工具和方法分析了沙特阿拉伯主要城市吉达的新冠疫苗接种中心的空间分布情况,以便从可及性和覆盖范围方面深入了解新冠疫苗接种中心的选址和分布效果。基于本研究中对吉达2020年和2021年疫苗接种中心覆盖范围的空间分析,如果当局在逐步增加接种中心数量的同时使用所应用的GIS分析方法,覆盖不足问题本可更早得到解决。本研究建议沙特阿拉伯卫生部评估已分配的疫苗接种中心,将人口较少的地区纳入其中,并确保疫苗分配的公平公正。还建议增加更多疫苗接种中心,或在人口密集地区重新分配一些现有中心,以扩大吉达未覆盖的稀疏地区的覆盖范围。本研究中应用的方法可成为未来突发公共卫生事件及其他疫苗接种活动战略疫苗接种管理计划的一部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/2190947838ba/ijerph-19-03526-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/08787bda0afb/ijerph-19-03526-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/ca74fdc2b925/ijerph-19-03526-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/270aba8273e9/ijerph-19-03526-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/8512fe6958ed/ijerph-19-03526-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/532305586728/ijerph-19-03526-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/d27548cee2f5/ijerph-19-03526-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/084bb90f5f89/ijerph-19-03526-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/e93e637f5c8a/ijerph-19-03526-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/4f34f6fc7748/ijerph-19-03526-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/a8684568f524/ijerph-19-03526-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/e0e32284aecf/ijerph-19-03526-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/c9162745f165/ijerph-19-03526-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/2063f27ec808/ijerph-19-03526-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/2190947838ba/ijerph-19-03526-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/08787bda0afb/ijerph-19-03526-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/ca74fdc2b925/ijerph-19-03526-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/270aba8273e9/ijerph-19-03526-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/8512fe6958ed/ijerph-19-03526-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/532305586728/ijerph-19-03526-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/d27548cee2f5/ijerph-19-03526-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/084bb90f5f89/ijerph-19-03526-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/e93e637f5c8a/ijerph-19-03526-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/4f34f6fc7748/ijerph-19-03526-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/a8684568f524/ijerph-19-03526-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/e0e32284aecf/ijerph-19-03526-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/c9162745f165/ijerph-19-03526-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/2063f27ec808/ijerph-19-03526-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283f/8948971/2190947838ba/ijerph-19-03526-g014.jpg

相似文献

1
Spatial Analysis of COVID-19 Vaccine Centers Distribution: A Case Study of the City of Jeddah, Saudi Arabia.新冠疫苗接种中心分布的空间分析:以沙特阿拉伯吉达市为例
Int J Environ Res Public Health. 2022 Mar 16;19(6):3526. doi: 10.3390/ijerph19063526.
2
Location-Allocation Model to Improve the Distribution of COVID-19 Vaccine Centers in Jeddah City, Saudi Arabia.用于改善沙特阿拉伯吉达市 COVID-19 疫苗接种中心分布的选址-分配模型。
Int J Environ Res Public Health. 2022 Jul 19;19(14):8755. doi: 10.3390/ijerph19148755.
3
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
4
Public acceptance of COVID-19 vaccination among residents of Saudi Arabia: a cross-sectional online study.沙特阿拉伯居民对 COVID-19 疫苗接种的公众接受度:一项横断面在线研究。
BMJ Open. 2022 Oct 31;12(10):e058180. doi: 10.1136/bmjopen-2021-058180.
5
SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.SARS-CoV-2 变体和疫苗接种率在 Delta 变体出现期间面临的全球大流行:一项旨在寻找疫苗犹豫原因的全国性调查。
J Infect Public Health. 2022 Jul;15(7):773-780. doi: 10.1016/j.jiph.2022.06.007. Epub 2022 Jun 17.
6
Public Knowledge, Attitude, and Perception towards COVID-19 Vaccination in Saudi Arabia.公众对沙特阿拉伯 COVID-19 疫苗接种的知识、态度和看法。
Int J Environ Res Public Health. 2021 Sep 25;18(19):10081. doi: 10.3390/ijerph181910081.
7
Socio-Demographics Correlate of COVID-19 Vaccine Hesitancy During the Second Wave of COVID-19 Pandemic: A Cross-Sectional Web-Based Survey in Saudi Arabia.社会人口统计学与 COVID-19 疫苗犹豫在 COVID-19 大流行第二波期间的相关性:沙特阿拉伯的一项基于网络的横断面调查。
Front Public Health. 2021 Jun 24;9:698106. doi: 10.3389/fpubh.2021.698106. eCollection 2021.
8
What motivated residents of Saudi Arabia to receive the COVID-19 vaccine?是什么促使沙特阿拉伯居民接种 COVID-19 疫苗?
Front Public Health. 2023 Feb 7;11:1065157. doi: 10.3389/fpubh.2023.1065157. eCollection 2023.
9
Acceptance and Attitude toward COVID-19 Vaccination among the Public in Saudi Arabia: A Cross-sectional Study.沙特阿拉伯公众对 COVID-19 疫苗接种的接受度和态度:一项横断面研究。
J Contemp Dent Pract. 2021 Jul 1;22(7):730-734.
10
Pattern of self-reported adverse events related to COVID-19 vaccines in Saudi Arabia: A nationwide study.沙特阿拉伯与 COVID-19 疫苗相关的不良事件自我报告模式:一项全国性研究。
Front Public Health. 2023 Feb 23;11:1043696. doi: 10.3389/fpubh.2023.1043696. eCollection 2023.

引用本文的文献

1
Location allocation approach based on influence of points of dispensing.基于配药点影响的选址分配方法
Sci Rep. 2025 Jul 28;15(1):27491. doi: 10.1038/s41598-025-12898-4.
2
Overcoming Health Inequities: Spatial Analysis of Seroprevalence and Vaccination Against COVID-19 in Chile.克服健康不平等:智利新冠病毒血清阳性率和疫苗接种情况的空间分析
Health Equity. 2024 Aug 26;8(1):558-567. doi: 10.1089/heq.2023.0204. eCollection 2024.
3
Analysis and prediction of infectious diseases based on spatial visualization and machine learning.

本文引用的文献

1
Understanding the spatio-temporal pattern of COVID-19 outbreak in India using GIS and India's response in managing the pandemic.利用地理信息系统(GIS)了解印度新冠肺炎疫情的时空模式以及印度在管理该疫情方面的应对措施。
Reg Sci Policy Prac. 2020 Dec;12(6):1063-1103. doi: 10.1111/rsp3.12359. Epub 2020 Nov 29.
2
Applications of GIS and geospatial analyses in COVID-19 research: A systematic review.GIS 和地理空间分析在 COVID-19 研究中的应用:系统评价。
F1000Res. 2020 Nov 27;9:1379. doi: 10.12688/f1000research.27544.2. eCollection 2020.
3
Spatiotemporal Assessment of COVID-19 Spread over Oman Using GIS Techniques.
基于空间可视化和机器学习的传染病分析与预测。
Sci Rep. 2024 Nov 19;14(1):28659. doi: 10.1038/s41598-024-80058-1.
4
Location-Allocation Model to Improve the Distribution of COVID-19 Vaccine Centers in Jeddah City, Saudi Arabia.用于改善沙特阿拉伯吉达市 COVID-19 疫苗接种中心分布的选址-分配模型。
Int J Environ Res Public Health. 2022 Jul 19;19(14):8755. doi: 10.3390/ijerph19148755.
利用地理信息系统技术对阿曼境内新冠病毒传播情况的时空评估
Earth Syst Environ. 2020;4(4):797-811. doi: 10.1007/s41748-020-00194-2. Epub 2020 Dec 8.
4
COVID-19 Vaccine Administration, by Race and Ethnicity - North Carolina, December 14, 2020-April 6, 2021.COVID-19 疫苗接种情况,按种族和族裔划分 - 北卡罗来纳州,2020 年 12 月 14 日-2021 年 4 月 6 日。
MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):991-996. doi: 10.15585/mmwr.mm7028a2.
5
Epidemiological characteristics and initial spatiotemporal visualisation of COVID-19 in a major city in the Middle East.中东主要城市 COVID-19 的流行病学特征及初始时空可视化。
BMC Public Health. 2021 Jul 12;21(1):1373. doi: 10.1186/s12889-021-11326-2.
6
Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward.在沙特阿拉伯启动 COVID-19 疫苗接种:经验教训和未来方向。
Travel Med Infect Dis. 2021 Sep-Oct;43:102119. doi: 10.1016/j.tmaid.2021.102119. Epub 2021 Jun 13.
7
The Use of GIS Technology to Optimize COVID-19 Vaccine Distribution: A Case Study of the City of Warsaw, Poland.利用 GIS 技术优化 COVID-19 疫苗分发:以波兰华沙市为例。
Int J Environ Res Public Health. 2021 May 25;18(11):5636. doi: 10.3390/ijerph18115636.
8
Will access to COVID-19 vaccine in Aotearoa be equitable for priority populations?在新西兰,优先人群能否公平地获得 COVID-19 疫苗?
N Z Med J. 2021 May 21;134(1535):25-35.
9
Dynamics of the COVID-19 epidemic in urban and rural areas in the United States.美国城乡地区新冠疫情动态
Ann Epidemiol. 2021 Jul;59:16-20. doi: 10.1016/j.annepidem.2021.04.007. Epub 2021 Apr 22.
10
Covid-19: Where are we on vaccines and variants?新冠疫情:我们在疫苗和病毒变种方面进展如何?
BMJ. 2021 Mar 2;372:n597. doi: 10.1136/bmj.n597.